NDC 85509-1031-01 - Omeprazole and Sodium Bicarbonate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 85509-1031
- Requested NDC
- 85509-1031-01
- Package NDCs from labels
- 85509-1031-1, 85509-1031-3, 85509-1031-6, 85509-1031-01
- Manufacturer
- PHOENIX RX LLC
- Effective date
- 2025-07-30
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Omeprazole and Sodium Bicarbonate - PHOENIX RX LLC | PHOENIX RX LLC | 2025-07-30 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 85509-1031-1 | Omeprazole and Sodium Bicarbonate | 15 in 1 BOTTLE | CAPSULE | 15 | 1 | |
| 85509-1031-3 | Omeprazole and Sodium Bicarbonate | 30 in 1 BOTTLE | CAPSULE | 30 | 1 | |
| 85509-1031-6 | Omeprazole and Sodium Bicarbonate | 60 in 1 BOTTLE | CAPSULE | 60 | 1 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 85509-1031-1 | EA - Each | 85509-1031 | 1c3c07fd-bae7-409a-a397-74b9327daee3 | 1 | 2025-09-12 |
| 85509-1031-3 | EA - Each | 85509-1031 | 3436b33a-5611-438a-ba52-51e9ccd61caa | 1 | 2025-09-12 |
| 85509-1031-6 | EA - Each | 85509-1031 | 8c060346-e9b5-4ba2-b1a5-e6beba9d6b35 | 1 | 2025-09-12 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Omeprazole | OMEPRAZOLE | St. Mary's Medical Park Pharmacy | 1eb57c13-25ed-70bc-e063-6294a90afdac | 2026-06-10 | Warnings, Adverse reactions | KG60484QX9 |
| Sodium Bicarbonate | SODIUM BICARBONATE | Exela Pharma Sciences, LLC | 2f05947f-a489-4298-a871-90db75b2a6c5 | 2026-06-09 | Warnings, Adverse reactions | 8MDF5V39QO |
| Omeprazole | OMEPRAZOLE | QPharma Inc | 50115204-74f7-17c1-e063-6394a90ab665 | 2026-06-08 | Warnings, Adverse reactions | KG60484QX9 |
| Sodium Bicarbonate Antacid | SODIUM BICARBONATE | NCS HealthCare of KY, LLC dba Vangard Labs | fde4ea0c-152b-4b79-a6d8-2b0dbd9107aa | 2026-06-04 | Warnings | 8MDF5V39QO |
| Humco Sodium Bicarbonate | SODIUM BICARBONATE | Humco Holding Group, Inc. | aeaa34f6-216d-49f3-8393-c7bda96a3e32 | 2026-05-26 | Warnings | 8MDF5V39QO |
| Alka-Seltzer Original | ANHYDROUS CITRIC ACID, ASPIRIN, AND SODIUM BICARBONATE | Select Consumer Group | 3ca80d74-1e8b-49d9-e063-6394a90a4312 | 2026-05-24 | Warnings | 8MDF5V39QO |
| Berkley and Jensen Omeprazole | OMEPRAZOLE | BJWC | f74752a8-a686-4c7d-91ad-8c87c4596a7a | 2026-05-21 | Warnings | KG60484QX9 |
| omeprazole | OMEPRAZOLE | Amazon.com Services LLC | 7e0d319c-6917-45c4-b7e1-e870fc3fcea5 | 2026-05-13 | Warnings | KG60484QX9 |
| Systane Pro PF | PROPYLENE GLYCOL | Alcon Laboratories, Inc. | a12baf3d-f22b-4c9f-a4c8-4e0d09f6d6f1 | 2026-05-12 | Warnings | 6DC9Q167V3 |
| Market Basket Effervescent Antacid and Pain Relief | ASPIRIN, CITRIC ACID, SODIUM BICARBONATE | Demoulas Super Markets, Inc. | e15439c7-0e3c-7752-e053-2995a90a1a40 | 2026-05-11 | Warnings | 8MDF5V39QO |
| Meijer Effervescent Antacid and Pain Relief | ASPIRIN, ANHYDROUS CITRIC ACID, SODIUM BICARBONATE | Meijer Distribution Inc | 7305972b-aa0f-4daa-e053-2991aa0adfd7 | 2026-05-11 | Warnings | 8MDF5V39QO |
| CVS Effervescent Antacid and Pain Reliever | ASPIRIN, ANHYDROUS CITRIC ACID, SODIUM BICARBONATE | CVS Pharmacy | 4ac63cf7-f064-30a1-e054-00144ff88e88 | 2026-05-11 | Warnings | 8MDF5V39QO |
| Omeprazole | OMEPRAZOLE | QPharma Inc | f6f6ad19-ff6a-7cd3-e053-6294a90ae1bf | 2026-05-11 | Warnings, Adverse reactions | KG60484QX9 |
| Sodium Bicarbonate | SODIUM BICARBONATE | Vitamex USA, Corp | 5195cab5-bdda-2ddf-e063-6394a90ac9fe | 2026-05-11 | Warnings | 8MDF5V39QO |
| Sodium Bicarbonate | SODIUM BICARBONATE | TWIN MED LLC | 0f867f56-4bc0-4a85-b9d2-a16282b7c82b | 2026-05-01 | Warnings | 8MDF5V39QO |
| Omeprazole | OMEPRAZOLE | Preferred Phharmaceuticals Inc. | 319d990e-161b-4c16-b026-f55c413c7e8f | 2026-04-21 | Warnings, Adverse reactions | KG60484QX9 |
| Omeprazole | OMEPRAZOLE | AMERISOURCEBERGEN DRUG CORPORATION | 0521c51b-d113-7e35-f1a6-c4495a2bcfcc | 2026-04-17 | Warnings | KG60484QX9 |
| care one omeprazole | OMEPRAZOLE | American Sales Company | db2d75ea-5924-4b7f-a92d-d4847a010d52 | 2026-04-17 | Warnings | KG60484QX9 |
| SODIUM BICARBONATE | SODIUM BICARBONATE | Medical Purchasing Solutions, LLC | 4f97d398-2118-0874-e063-6394a90a4ad1 | 2026-04-16 | Warnings, Adverse reactions | 8MDF5V39QO |
| PEG 3350 and Electrolytes | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | Wilshire Pharmaceuticals, Inc. | b251752d-7750-482a-9364-0acf4ad47cc8 | 2026-04-16 | Warnings, Adverse reactions | 8MDF5V39QO |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.